title: The effect of unrelated donor marrow transplantation on health-related quality of life: a report of the unrelated donor marrow transplantation trial (T-cell depletion trial).
abstract: The primary objective of this study was to compare health-related quality of life (HRQL) in adult patients undergoing either ex vivo T cell-depleted bone marrow transplantation or conventional marrow transplantation. Data on patients' HRQL were gathered as part of a multicenter randomized trial comparing the effect of ex vivo T-cell depletion versus methotrexate and cyclosporine immunosuppression on disease-free survival. HRQL assessments were conducted at baseline, day +100, 6 months, 1 year, and 3 years. There were no treatment arm differences 1 year after transplantation on the Functional Assessment of Cancer Therapy, Bone Marrow Transplantation, the Medical Outcomes Study Short-Form 36, and the Centers for Epidemiological Studies of Depression. The lack of treatment differences was robust across types of data analyses that took baseline functioning into account and that recognized the sensitivity of outcome measures to assumptions concerning missing data. The trajectory of recovery revealed an initial decrease in function and then a recovery to pretreatment levels that were similar for both treatment arms. Furthermore, the patients in both treatment groups returned to a functional level that approximated general US population norms. Even though the incidence of acute graft-versus-host disease was slightly higher in the conventional treatment arm, T-cell depletion did not differentially affect HRQL at 1 year after transplantation.
authors.affiliation: The University of Iowa, and University of Iowa Hospitals and Clinics, Iowa City 52242, USA. elizabeth-altmaier@uiowa.edu
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Altmaier
authors.forename: Marian
authors.initials: M
authors.lastname: Ewell
authors.forename: Richard
authors.initials: R
authors.lastname: McQuellon
authors.forename: Nancy
authors.initials: N
authors.lastname: Geller
authors.forename: Shelly L
authors.initials: SL
authors.lastname: Carter
authors.forename: Jean
authors.initials: J
authors.lastname: Henslee-Downey
authors.forename: Stella
authors.initials: S
authors.lastname: Davies
authors.forename: Esperanza
authors.initials: E
authors.lastname: Papadopoulos
authors.forename: Saul
authors.initials: S
authors.lastname: Yanovich
authors.forename: Roger
authors.initials: R
authors.lastname: Gingrich
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D005500:Follow-Up Studies; D006304:Health Status; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007407:Interviews as Topic; D008212:Lymphocyte Depletion; D011788:Quality of Life; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data
chemical_list: D007166:Immunosuppressive Agents